Epinephrine Injection, Solution
Product Images NDC 51662-1476

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Epinephrine (NDC 51662-1476). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.1 mg 2 Pack And Trainer Box (0.1 mg 2 Pack And Trainer Box)

Packaging label for Auvi-q epinephrine injection USP 0.1 mg auto-injector for allergic emergencies in patients weighing 16.5 lb to 33 lb. The carton includes 2 prefilled auto-injectors plus 1 trainer. Label shows storage instructions, inactive ingredients, and manufacturer details by kaleo, Inc. with a caution to replace auto-injector if solution appears discolored or cloudy.*

FDA Label Image

0.1 mg 2 Pack And Trainer Serialized Carton (0.1 mg 2 Pack And Trainer Serialized Box)

Packaging label for Auvi-q epinephrine injection, USP 0.1 mg auto-injector. The label states it is for allergic emergencies in patients weighing 16.5 lb to 33 lb. The package contains 2 prefilled auto-injectors and 1 trainer. Distributed by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Injector Labeling 1 (0.1 mg Injector Labeling 1)

Packaging label for Auvi-q epinephrine injection, USP 0.1 mg auto-injector. The label includes usage instructions for allergic emergencies, warning to seek medical attention, and manufacturer information for Kaleo, Inc. in Richmond, VA. It specifies a single-use injection and advises disposal instructions after use. The label background is primarily purple and white with red, black, and gray text.*

FDA Label Image

A (A)

An instructional diagram showing two components of an epinephrine injection device: the Device and the Outer Case. The Device features labeled parts including a speaker, LED lights, a viewing window, a red safety guard at the needle end, and a black base. The Outer Case displays a blue top and a green arrow pointing upward.*

FDA Label Image

B (B)

An instructional illustration showing hands holding and manipulating an epinephrine autoinjector device. Arrows indicate the motion of pushing or sliding parts of the device, suggesting steps to prepare it for use or remove a safety cap. The image depicts user interaction with the injection device but no text is shown.*

FDA Label Image

C (C)

An instructional illustration showing a hand holding an epinephrine auto-injector device with arrows indicating downward pressure. The image demonstrates how to properly position and press the device against the thigh for administration.*

FDA Label Image

D (D)

An instructional illustration showing a person holding an autoinjector against their thigh, indicating the proper intramuscular injection site. A stopwatch graphic beside the figure shows a duration of 2 seconds, likely indicating how long to hold the device in place during administration.*

FDA Label Image

Device Label

Auvi-q epinephrine injection USP 0.1 mg auto-injector principal display panel with purple background. The label specifies contents per 0.1 mL: 0.1 mg epinephrine, 0.78 mg sodium chloride, 0.15 mg sodium bisulfite, and water for injection. Instructions for allergic emergencies include pulling the red safety guard and pushing the black end against outer thigh. Label indicates single-use, refill prescription, and manufacturer Kaleo, Inc., Richmond, VA.*

FDA Label Image

E (E)

An instructional illustration showing a hand holding an autoinjector device pressing it against a blue surface, with concentric red circles indicating the injection site. Next to this is a stopwatch graphic highlighting a 2-second countdown, indicating hold time after activation.*

FDA Label Image

Injector Labeling 2 (Injector Labeling 2)

Label for Auvi-q epinephrine injection USP 0.1 mg auto-injector. Designed for single-use injection for allergic emergencies in patients weighing 16.5 to 33 lb. Label includes storage instructions, manufacturer kaléo, and usage instructions on the device.*

FDA Label Image

Outer Case Labeling

Label for Auvi-q epinephrine injection USP 0.1 mg auto-injector, intended for single-use injection in patients weighing 16.5 lb to 33 lb. The label includes storage instructions to avoid refrigeration, freezing, heat, and light. Manufactured for Kaleo, the packaging instructs to pull the device up from the case for use.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of epinephrine showing its molecular arrangement with hydroxyl groups and amine substituents attached to a benzene ring.*

FDA Label Image

Serialized Label 1 Pack

A white rectangular label showing a 2D barcode and various identification numbers including a GTIN (01) and lot number (10). The label states distribution by HF Acquisition Co., LLC in Mukilteo, WA 98275, and includes the text 'See manufacturer's package insert' and 'RX ONLY' on the right side. The label is for EPINEPHRINE injection, solution, 0.1 mg/0.1 mL, intramuscular, from HF Acquisition Co LLC.*

FDA Label Image

Trainer Instructions (Trainer Inst)

Instructional diagram showing the TRAINER for AUVI-Q, a gray outer case device without needle or medicine designed for practice use. It includes labeled illustrations of the device components, colored AUVI-Q injectors (orange, blue, white and lavender) with respective epinephrine dosages, and step-by-step usage instructions on how to hold and operate the trainer on the thigh. The instructions emphasize safe practice before real use and explain resetting and handling the device after use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.